Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Balk

Showing results (21-30 of 189) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Biology of prostate-specific antigenSteven P Balk, Yoo-Joung Ko, Glenn J Bubley
Current Protocols in Immunology|April 25, 2008
Isolation and functional use of human NK T cellsMark A Exley, Steven P Balk, S Brian Wilson
The Prostate|July 22, 2008
Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteinsRamneet Kaur, Xin Yuan, Michael L Lu, et al.
Cell & Bioscience|June 23, 2018
Calcium signaling: an underlying link between cardiac disease and carcinogenesisXuehong Xu, Steven P Balk, William B Isaacs, et al.
Cancer Discovery|May 20, 2014
PTEN-deficient tumors depend on AKT2 for maintenance and survivalY Rebecca Chin, Xin Yuan, Steven P Balk, et al.
The Journal of Biological Chemistry|March 17, 2010
Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunitsXinnong Jiang, Sen Chen, John M Asara, et al.
Journal of Virology|July 1, 2006
CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivoPetr O Ilyinskii, Ruojie Wang, Steven P Balk, et al.
Cancer Research|July 9, 2009
Reactivation of androgen receptor-regulated TMPRSS2:ERG gene expression in castration-resistant prostate cancerChangmeng Cai, Hongyun Wang, Youyuan Xu, et al.
Cancer Research|September 7, 2007
Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressorsMyles C Hodgson, Inna Astapova, Anthony N Hollenberg, et al.
JCO Precision Oncology|February 24, 2022
A Case of Prostate Cancer Harboring Androgen Receptor T878A Progesterone-Responsive Mutant Emerging After Abiraterone Acetate Treatment Responding to DarolutamideAndreas Varkaris, Julia Stevens, Yuho Ono, et al.
Pageof 19

Showing results (21-30 of 189) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Biology of prostate-specific antigenSteven P Balk, Yoo-Joung Ko, Glenn J Bubley
Current Protocols in Immunology|April 25, 2008
Isolation and functional use of human NK T cellsMark A Exley, Steven P Balk, S Brian Wilson
The Prostate|July 22, 2008
Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteinsRamneet Kaur, Xin Yuan, Michael L Lu, et al.
Cell & Bioscience|June 23, 2018
Calcium signaling: an underlying link between cardiac disease and carcinogenesisXuehong Xu, Steven P Balk, William B Isaacs, et al.
Cancer Discovery|May 20, 2014
PTEN-deficient tumors depend on AKT2 for maintenance and survivalY Rebecca Chin, Xin Yuan, Steven P Balk, et al.
The Journal of Biological Chemistry|March 17, 2010
Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunitsXinnong Jiang, Sen Chen, John M Asara, et al.
Journal of Virology|July 1, 2006
CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivoPetr O Ilyinskii, Ruojie Wang, Steven P Balk, et al.
Cancer Research|July 9, 2009
Reactivation of androgen receptor-regulated TMPRSS2:ERG gene expression in castration-resistant prostate cancerChangmeng Cai, Hongyun Wang, Youyuan Xu, et al.
Cancer Research|September 7, 2007
Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressorsMyles C Hodgson, Inna Astapova, Anthony N Hollenberg, et al.
JCO Precision Oncology|February 24, 2022
A Case of Prostate Cancer Harboring Androgen Receptor T878A Progesterone-Responsive Mutant Emerging After Abiraterone Acetate Treatment Responding to DarolutamideAndreas Varkaris, Julia Stevens, Yuho Ono, et al.
Pageof 19